TC‐1734: An Orally Active Neuronal Nicotinic Acetylcholine Receptor Modulator with Antidepressant, Neuroprotective and Long‐Lasting Cognitive Effects

The development of selective ligands targeting neuronal nicotinic acetylcholine receptors to alleviate symptoms associated with neurodegenerative diseases presents the advantage of affecting multiple deficits that are the hallmarks of these pathologies. TC‐1734 is an orally active novel neuronal nic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CNS Drug Rev
Main Authors: Gatto, Gregory J., Bohme, G Andrees, Caldwell, William S., Letchworth, Sharon R., Traina, Vincent M., Obinu, M. Carmen, Laville, Michel, Reibaud, Michel, Pradier, Laurent, Dunbar, Geoffrey, Bencherif, Merouane
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2006
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6741718/
https://ncbi.nlm.nih.gov/pubmed/15179444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2004.tb00010.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados